FDA
-
-
-
-
-
-
-
Aerie Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Aerie Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call on Thursday, May 5, 2022 at 5:00 p.m. ET
-
-
-
-
-
-
-
Aerie Pharma (AERI) Appoints Gary Sternberg as Chief Medical Officer
-
-
-
-
-
-
-
Aerie Concludes Exclusive License Agreement With Santen for Rhopressa® and Rocklatan® in Europe and Several Other Regions
-
-
-
-
-
-
-
Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit Retina Innovation Showcase
-
-
-
-
-
-
-
Aerie Pharma (AERI) Selloff May Be Unwarranted, Secondary Data Could Lead to Phase 3 - Mizuho
-
-
-
-
-
-
-
Aerie Pharma (AERI) Misses Q2 EPS by 3c
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

